Amgen
PulseAugur coverage of Amgen — every cluster mentioning Amgen across labs, papers, and developer communities, ranked by signal.
1 天有情绪数据
-
Amgen leverages AI to speed up clinical development
Amgen is integrating artificial intelligence into its clinical development processes to accelerate drug discovery and improve trial efficiency. The company is exploring AI for tasks such as identifying patient cohorts, …
-
National IC Fund II cuts Baiwei Storage stake; BeiGene revenue surges 31%
National Integrated Circuit Fund II has reduced its stake in Biwin Storage by 1.85% between February 4th and May 3rd, 2026. This reduction involved selling 8.69 million shares through block and concentrated bidding tran…
-
百济神州公布第一季度利润16亿元，得益于强劲的药品销售
百济神州公布了其2026年第一季度的财务业绩，报告归属于母公司所有者的净利润为16.08亿元。这标志着与去年同期亏损相比实现了显著的扭亏为盈。公司营收同比增长31.0%，达到105.44亿元，这主要得益于其关键产品（包括BeiYueZe®、安进授权产品和BeiZeAn®）的强劲销售。
-
FDA pilots real-time AI cloud clinical trials with AstraZeneca and Amgen
The U.S. Food and Drug Administration (FDA) has launched a pilot program utilizing real-time AI and cloud technology for clinical trials. This initiative involves major pharmaceutical companies AstraZeneca and Amgen. Th…